We are driven to advance care by delivering breakthrough cancer therapies to patients who need them.
Our mission is to make exceptional, innovative biopharmaceuticals to improve the lives of patients suffering from serious diseases. Our focus is on cancer. Innovative technologies and smart development strategies are central to our approach.Learn About Our Mission
As of July 15, 2021, Constellation Pharmaceuticals is a MorphoSys company. Together, we are committed to delivering breakthrough therapies that bring hope to life. Learn more about MorphoSys’ acquisition of Constellation Pharmaceuticals. View Details Here >